352 related articles for article (PubMed ID: 28591206)
1. ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1).
Hayes DA; Kunde DA; Taylor RL; Pyecroft SB; Sohal SS; Snow ET
PLoS One; 2017; 12(6):e0177919. PubMed ID: 28591206
[TBL] [Abstract][Full Text] [Related]
2. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
Patchett AL; Flies AS; Lyons AB; Woods GM
Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
[TBL] [Abstract][Full Text] [Related]
3. Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii).
Patchett AL; Coorens THH; Darby J; Wilson R; McKay MJ; Kamath KS; Rubin A; Wakefield M; Mcintosh L; Mangiola S; Pye RJ; Flies AS; Corcoran LM; Lyons AB; Woods GM; Murchison EP; Papenfuss AT; Tovar C
Cell Mol Life Sci; 2020 May; 77(9):1847-1858. PubMed ID: 31375869
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicle proteomes of two transmissible cancers of Tasmanian devils reveal tenascin-C as a serum-based differential diagnostic biomarker.
Espejo C; Wilson R; Willms E; Ruiz-Aravena M; Pye RJ; Jones ME; Hill AF; Woods GM; Lyons AB
Cell Mol Life Sci; 2021 Dec; 78(23):7537-7555. PubMed ID: 34655299
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials.
Patchett AL; Tovar C; Blackburn NB; Woods GM; Lyons AB
Immunol Cell Biol; 2021 Aug; 99(7):711-723. PubMed ID: 33667023
[TBL] [Abstract][Full Text] [Related]
6. Automated Analysis of PD1 and PDL1 Expression in Lymph Nodes and the Microenvironment of Transmissible Tumors in Tasmanian Devils.
Russell GG; Palmieri C; Darby J; Morris GP; Fountain-Jones NM; Pye RJ; Flies AS
Immunol Invest; 2023 Nov; 52(6):661-680. PubMed ID: 37267050
[TBL] [Abstract][Full Text] [Related]
7. The evolution of two transmissible cancers in Tasmanian devils.
Stammnitz MR; Gori K; Kwon YM; Harry E; Martin FJ; Billis K; Cheng Y; Baez-Ortega A; Chow W; Comte S; Eggertsson H; Fox S; Hamede R; Jones M; Lazenby B; Peck S; Pye R; Quail MA; Swift K; Wang J; Wood J; Howe K; Stratton MR; Ning Z; Murchison EP
Science; 2023 Apr; 380(6642):283-293. PubMed ID: 37079675
[TBL] [Abstract][Full Text] [Related]
8. A second transmissible cancer in Tasmanian devils.
Pye RJ; Pemberton D; Tovar C; Tubio JM; Dun KA; Fox S; Darby J; Hayes D; Knowles GW; Kreiss A; Siddle HV; Swift K; Lyons AB; Murchison EP; Woods GM
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):374-9. PubMed ID: 26711993
[TBL] [Abstract][Full Text] [Related]
9. A human adenovirus encoding IFN-γ can transduce Tasmanian devil facial tumour cells and upregulate MHC-I.
Kayigwe AN; M Darby J; Lyons AB; L Patchett A; Lisowski L; Liu GS; S Flies A
J Gen Virol; 2022 Nov; 103(11):. PubMed ID: 36382885
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of Cryptosporidium and Giardia from the Tasmanian devil (Sarcophilus harrisii).
Wait LF; Fox S; Peck S; Power ML
PLoS One; 2017; 12(4):e0174994. PubMed ID: 28423030
[TBL] [Abstract][Full Text] [Related]
11. Evolution and lineage dynamics of a transmissible cancer in Tasmanian devils.
Kwon YM; Gori K; Park N; Potts N; Swift K; Wang J; Stammnitz MR; Cannell N; Baez-Ortega A; Comte S; Fox S; Harmsen C; Huxtable S; Jones M; Kreiss A; Lawrence C; Lazenby B; Peck S; Pye R; Woods G; Zimmermann M; Wedge DC; Pemberton D; Stratton MR; Hamede R; Murchison EP
PLoS Biol; 2020 Nov; 18(11):e3000926. PubMed ID: 33232318
[TBL] [Abstract][Full Text] [Related]
12. Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells.
Ong CEB; Lyons AB; Woods GM; Flies AS
Front Immunol; 2018; 9():3117. PubMed ID: 30692995
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
[TBL] [Abstract][Full Text] [Related]
14. Devil Facial Tumours: Towards a Vaccine.
Owen RS; Siddle HV
Immunol Invest; 2019 Oct; 48(7):719-736. PubMed ID: 31161832
[TBL] [Abstract][Full Text] [Related]
15. Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases.
Kwon YM; Stammnitz MR; Wang J; Swift K; Knowles GW; Pye RJ; Kreiss A; Peck S; Fox S; Pemberton D; Jones ME; Hamede R; Murchison EP
R Soc Open Sci; 2018 Oct; 5(10):180870. PubMed ID: 30473836
[TBL] [Abstract][Full Text] [Related]
16. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
[TBL] [Abstract][Full Text] [Related]
17. The differentiation state of the Schwann cell progenitor drives phenotypic variation between two contagious cancers.
Owen RS; Ramarathinam SH; Bailey A; Gastaldello A; Hussey K; Skipp PJ; Purcell AW; Siddle HV
PLoS Pathog; 2021 Nov; 17(11):e1010033. PubMed ID: 34780568
[TBL] [Abstract][Full Text] [Related]
18. Hematologic and serum biochemical changes associated with Devil Facial Tumor Disease in Tasmanian Devils.
Peck S; Corkrey R; Hamede R; Jones M; Canfield P
Vet Clin Pathol; 2016 Sep; 45(3):417-29. PubMed ID: 27589840
[TBL] [Abstract][Full Text] [Related]
19. Causes of mortality and severe morbidity requiring euthanasia in captive Tasmanian devils (Sarcophilus harrisii) in Tasmania.
Peck SJ; Michael SA; Knowles G; Davis A; Pemberton D
Aust Vet J; 2019 Apr; 97(4):89-92. PubMed ID: 30919442
[TBL] [Abstract][Full Text] [Related]
20. The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer.
Caldwell A; Coleby R; Tovar C; Stammnitz MR; Kwon YM; Owen RS; Tringides M; Murchison EP; Skjødt K; Thomas GJ; Kaufman J; Elliott T; Woods GM; Siddle HV
Elife; 2018 Aug; 7():. PubMed ID: 30103855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
